Postdoc - Deciphering resistance against targeted treatments in glioblastoma (m/w/d)

The University Hospital Heidelberg is one of the major healthcare centers in Germany. Our objective is the development of innovative diagnostics and therapies as well as their quick implementation for the patient. With about 14,000 employees in more than 50 specialized clinical departments with almost 2,500 beds, about 80,000 patients in part-time and full-time inpatient treatment as well as 1,000,000 patients in ambulant treatment are medicated each year.

Postdoc - Deciphering resistance against targeted treatments in glioblastoma (m/w/d)

wanted for the next possible date at the Division of Neuro-oncology at the Department of Neurology.

The Department of Neurology at Heidelberg University Hospital is looking for a postdoctoral researcher (PhD, MD, or equivalent) to work as part of the established Collaborative Research Center (Sonderforschungsbereich) CRC/SFB 1389 Understanding and Targeting Resistance in Glioblastoma (UNITE Glioblastoma). UNITE is supported by the Heidelberg Medical Faculty, Mannheim Medical Faculty and the German Cancer Research Center (DKFZ). These institutions stand out for their strong emphasis on interdisciplinary biomedical research and integrate adult and pediatric brain tumor expertise and networks at all levels. UNITE focuses on unraveling mechanisms of intrinsic resistance and mechanisms of resistance conferred by the microenvironment. Utilizing state-of the art technological innovation, novel high-throughput technologies, preclinical models, and AI based computational analytical tools are developed, applied, and shared as a resource within the initiative. Integrated cores for tissue material, including a core set of jointly used patient-derived models, and integrative data analysis support all principle investigators to efficiently use personal multi-dimensional-omic data for therapy guidance and precision medicine. By drawing a multidimensional map of therapy resistance, UNITE aims to develop concepts to predict and monitor treatment response and failure, and ultimately, to invent novel (combination) therapies for glioblastoma patients.

• Job-ID: V000015637
• Field of application: Neurologische Klinik
• Location: Heidelberg
• Job Category: Science and teaching
• Working hours: full-time
• Limitation: Temporary (2 years, extension is sought)
• Contract: TV-L